Fetalix has been featured in Expresso in the article “A Costa das Dores”, which explores new perspectives and solutions for pain-related healthcare challenges. The piece highlights Fetalix’s technology and its potential role in advancing treatment options for low back pain.
The article emphasizes the importance of innovative regenerative strategies in addressing intervertebral disc degeneration, a major underlying cause of chronic low back pain and a condition with limited long-term treatment solutions.
It also reflects growing interest in biomaterial-based approaches that aim not only to manage symptoms, but to support tissue repair and functional restoration.This recognition contributes to increasing public and professional awareness of regenerative medicine approaches and reinforces the relevance of science-driven innovation in tackling complex medical conditions.
May 26, 2023
